Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.

CSPC Pharmaceutical Group (SEHK:1093) has received regulatory approval in China to start clinical trials for its new antibody drug conjugate SYS6051. The therapy targets advanced solid tumors and has ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

In business as in medicine, a remedy can take time to kick in. This is the challenge for Chinese drug giant CSPC Pharmaceutical Group Ltd. (1093.HK), which is trying to transform itself from being a ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

CSPC Pharmaceutical Group (01093.HK) announced that the Groups Class 1 chemical innovative drug SYH2095 Tablet, jointly ...

Narrow-moat CSPC’s 01093 interim results fell short of expectations. Revenue for the six months grew 3% year on year whereas operating profit, calculated with cost of sales and expenses for sales, ...

Verastem Oncology to Receive an Upfront Payment of $15 Million USD; Then Eligible to Receive Up To $30 Million USD in Development Milestone Payments as well as Sales Milestone and Double-Digit ...

China’s health authorities have approved clinical trials of two Covid-19 vaccines that use mRNA, potentially adding an option to the nation’s arsenal in its battle against the pandemic’s worst ...